1. Home
  2. DBVT vs ZENA Comparison

DBVT vs ZENA Comparison

Compare DBVT & ZENA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DBVT
  • ZENA
  • Stock Information
  • Founded
  • DBVT 2002
  • ZENA 2017
  • Country
  • DBVT France
  • ZENA Canada
  • Employees
  • DBVT N/A
  • ZENA N/A
  • Industry
  • DBVT Biotechnology: Biological Products (No Diagnostic Substances)
  • ZENA
  • Sector
  • DBVT Health Care
  • ZENA
  • Exchange
  • DBVT Nasdaq
  • ZENA NYSE
  • Market Cap
  • DBVT 102.0M
  • ZENA 82.4M
  • IPO Year
  • DBVT N/A
  • ZENA N/A
  • Fundamental
  • Price
  • DBVT $6.46
  • ZENA $2.69
  • Analyst Decision
  • DBVT Strong Buy
  • ZENA
  • Analyst Count
  • DBVT 2
  • ZENA 0
  • Target Price
  • DBVT $22.50
  • ZENA N/A
  • AVG Volume (30 Days)
  • DBVT 1.1M
  • ZENA 614.6K
  • Earning Date
  • DBVT 05-06-2025
  • ZENA 01-01-0001
  • Dividend Yield
  • DBVT N/A
  • ZENA N/A
  • EPS Growth
  • DBVT N/A
  • ZENA N/A
  • EPS
  • DBVT N/A
  • ZENA N/A
  • Revenue
  • DBVT $4,200,000.00
  • ZENA $1,476,462.00
  • Revenue This Year
  • DBVT $1,679.52
  • ZENA N/A
  • Revenue Next Year
  • DBVT $535.67
  • ZENA N/A
  • P/E Ratio
  • DBVT N/A
  • ZENA N/A
  • Revenue Growth
  • DBVT N/A
  • ZENA 9.19
  • 52 Week Low
  • DBVT $0.44
  • ZENA $1.41
  • 52 Week High
  • DBVT $7.28
  • ZENA $12.43
  • Technical
  • Relative Strength Index (RSI)
  • DBVT 65.77
  • ZENA N/A
  • Support Level
  • DBVT $3.91
  • ZENA N/A
  • Resistance Level
  • DBVT $7.28
  • ZENA N/A
  • Average True Range (ATR)
  • DBVT 0.60
  • ZENA 0.00
  • MACD
  • DBVT 0.20
  • ZENA 0.00
  • Stochastic Oscillator
  • DBVT 75.67
  • ZENA 0.00

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Viaskin targets specific antigen-presenting immune cells in the skin, called Langerhans cells, that capture the antigen and migrate to the lymph node to activate the immune system without passage of the antigen into the bloodstream, minimizing systemic exposure in the body. Its main product candidate is Viaskin Peanut for the treatment of peanut-allergic patients.

About ZENA ZENATECH INC

ZenaTech Inc is a enterprise software technology company that specializes in mission-critical cloud-based applications integrated with smart hardware to deliver innovative solutions across diverse industries. The Company operates in software development technology, sales, and distribution. The Company is also developing a drone manufacturing, sales, and distribution business. The company operates in two segments which is software development technology, sales, and distribution, as well as drone manufacturing, sales, and distribution.

Share on Social Networks: